Network for Monitoring the Impact of Globalization and TRIPS on Access to Medicines, Meeting Report, 19-21 February 2001, Chulalongkorn University, Bangkok, Thailand - Health Economics and Drugs Series No. 011
(2002; 67 pages) View the PDF document
Table of Contents
Open this folder and view contents1. Introduction
View the document2. Highlights of opening address of Dr Supachai Panitchpakdi
Open this folder and view contents3. 1Globalization, TRIPS and Access to Pharmaceuticals
View the document4. Further Reading
View the document5. Template of selected model indicators for studying the impact of globalization and TRIPS on access to medicines
Close this folder6. Selected indicators for studying the impact of globalization and TRIPS on access to medicines
View the documentRespondent data
Close this folderContents
View the documentI. Definitions used in the template**
View the documentII. Trends in total pharmaceutical consumption
View the documentIII. Health care coverage
View the documentIV. Structure of public and private pharmaceutical prices
View the documentV. Regulations relating to intellectual property rights protection and marketing authorization
View the documentVI. Prices of pharmaceutical products
View the documentVII. Market share of domestic and foreign firms
View the documentVIII. Regulation of pharmaceutical consumption - A stakeholder analysis
View the document7. The Collaborating Centres

III. Health care coverage

Table C: Health care coverage


Percentage of population covered by public health care system

Percentage of population covered by private health care insurance

Percentage of population not covered by any public or private health care scheme













1. Are pharmaceuticals covered by health insurance or health service schemes?


a) Is there any co-payment?

If yes, how much?

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017